Red blood cell-derived microparticles
complexRBC-derived microparticles marking thrombotic activation and hemolysis during acute coronary occlusion.
Pathway placement
Cascade stepCoagulation & thrombus formation
Confidencemedium
RationaleRBC-derived vesicles; markers of ongoing thrombosis and hemolytic stress in acute MI.
Also acts inPlatelet activation
Druggability
Not assessed (no mapped human gene target).
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Plasma (citrate for coagulation complexes)
Collection tube
Sodium citrate 3.2% (light blue-top) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich ELISA against neo-complex epitope
Reagent / substrate
Antibody pair recognizing the assembled complex
Platform
ELISA plate
Turnaround · availability
Research / send-out · Research/specialized
Literature evidence(1)
- Cell-Derived Microparticles and Acute Coronary Syndromes: Is there a Predictive Role for Microparticles?Current medicinal chemistry · 2020 · PMID 31838988 · doi